EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Usefulness of the BD MAX MDR-TB Molecular Test in the Rapid Diagnosis of Multidrug-Resistant Tuberculosis

Tomasz Bogiel iD, Edyta Dolska, Małgorzata Zimna, Kornelia Nakonowska, Dorota Krawiecka, Renata Żebracka, Maciej Pochowski, Agnieszka Krawczyk iD

Pathogens · 19.06.2025 · 14 (6) · 602

DOI: 10.3390/pathogens14060602 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, online erschienen am 19.06.2025. Verfasst von Tomasz Bogiel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Propaedeutics of Medicine and Infection Prevention Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in To…. Hauptthemen laut MEDLINE: Tuberculosis, Multidrug-Resistant, Mycobacterium tuberculosis, Molecular Diagnostic Techniques, Drug Resistance, Multiple, Bacterial. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nicolaus Copernicus University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis (TB), primarily caused by Mycobacterium tuberculosis complex (MTBC), remains a global health challenge and can lead to severe pulmonary and extrapulmonary complications. Multidrug-resistant TB (MDR-TB) poses additional challenges, requiring advanced diagnostic and treatment strategies. This study evaluates the BD MAX MDR-TB molecular test for a rapid diagnosis of MDR-TB, detecting resistance to rifampicin (RIF) and isoniazid (INH). The BD MAX MDR-TB test, utilizing real-time PCR, was used to analyze specimens collected from TB-suspected patients, identifying MTB DNA and mutations associated with rifampicin and isoniazid resistance. Results were compared with traditional drug susceptibility testing, and 79 out of 638 samples tested were positive for MTB DNA, with 65 showing a sufficient amount of genetic material for resistance gene identification. The BD MAX test showed a 100% correlation with phenotypic rifampicin resistance, though discrepancies were noted for isoniazid resistance, with a 93% concordance. The BD MAX MDR-TB test is an effective tool for a rapid diagnosis of MDR-TB, especially for rifampicin resistance. However, it may not detect certain mutations related to isoniazid resistance. Complementary tests like Xpert MTB/XDR or whole-genome sequencing could improve diagnostic accuracy and support more effective TB control strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberculosis, Multidrug-ResistantMycobacterium tuberculosisMolecular Diagnostic TechniquesDrug Resistance, Multiple, BacterialHumansRifampinIsoniazidAntitubercular AgentsMicrobial Sensitivity TestsMutationReal-Time Polymerase Chain ReactionDNA, BacterialSensitivity and Specificity

Stichwörter der Autor:innen

BD MAX MDR-TBMycobacterium tuberculosis complexisoniazidmultidrug-resistant tuberculosisrifampicintuberculosis

Substanzen

RifampinIsoniazidAntitubercular AgentsDNA, Bacterial

Autor:innen und Institutionen

  • Department of Propaedeutics of Medicine and Infection Prevention Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 9 Maria Skłodowska-Curie Street, 85-094 Bydgoszcz, Poland.
  • Clinical Microbiology Laboratory, Dr. Antoni Jurasz University Hospital No. 1 in Bydgoszcz, 9 Maria Skłodowska-Curie Street, 85-094 Bydgoszcz, Poland.
  • Department of Microbiological Diagnostics, Kujawsko-Pomorskie Pulmonology Centre in Bydgoszcz, 85-326 Bydgoszcz, Poland.
  • Department of Molecular Medical Microbiology, Chair of Microbiology, Jagiellonian University Medical College, 31-121 Kraków, Poland.

ORCID-Profile: Tomasz Bogiel, Agnieszka Krawczyk

Förderung

  • Nicolaus Copernicus University

Zitieren

APA

Bogiel, T., Dolska, E., Zimna, M., Nakonowska, K., Krawiecka, D., Żebracka, R., Pochowski, M., & Krawczyk, A. (2025). The Usefulness of the BD MAX MDR-TB Molecular Test in the Rapid Diagnosis of Multidrug-Resistant Tuberculosis. Pathogens, 14(6), 602. https://doi.org/10.3390/pathogens14060602

Vancouver

Bogiel T, Dolska E, Zimna M, Nakonowska K, Krawiecka D, Żebracka R, et al. The Usefulness of the BD MAX MDR-TB Molecular Test in the Rapid Diagnosis of Multidrug-Resistant Tuberculosis. Pathogens. 2025;14(6):602. doi:10.3390/pathogens14060602

BibTeX
@article{Bogiel2025,
  author = {Bogiel, Tomasz and Dolska, Edyta and Zimna, Małgorzata and Nakonowska, Kornelia and Krawiecka, Dorota and Żebracka, Renata and Pochowski, Maciej and Krawczyk, Agnieszka},
  title = {The Usefulness of the BD MAX MDR-TB Molecular Test in the Rapid Diagnosis of Multidrug-Resistant Tuberculosis},
  journal = {Pathogens},
  year = {2025},
  volume = {14},
  number = {6},
  pages = {602},
  doi = {10.3390/pathogens14060602}
}
Kostenlos starten →